NCT06149273 Treatment of Insomnia in Primary Care Study
| NCT ID | NCT06149273 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Turku |
| Condition | Insomnia Chronic |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2023-12-02 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2023-12-02 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn about insomnia treatment among primary care patients with chronic insomnia. The main question it aims to answer is: • Does Sleep School (a therapy for insomnia) work well to decrease harm of insomnia? Participants will attend a group therapy intervention once a week for six weeks. Researchers will compare Sleep School to treatment as usual (short counselling by an educated nurse) to see if the Sleep School works better than treatment as usual in decreasing the harm of insomnia.
Eligibility Criteria
Inclusion Criteria: * Insomnia severity index (ISI) score at least 8 * insomnia symptoms present at least for 3 months Exclusion Criteria: * diagnosed dementia based on medical records * acute suicidality * acute psychotic symptoms
Contact & Investigator
Päivi Korhonen, PhD
PRINCIPAL INVESTIGATOR
University of Turku
Frequently Asked Questions
Who can join the NCT06149273 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Insomnia Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06149273 currently recruiting?
Yes, NCT06149273 is actively recruiting participants. Contact the research team at elkaro@utu.fi for enrollment information.
Where is the NCT06149273 trial being conducted?
This trial is being conducted at Turku, Finland.
Who is sponsoring the NCT06149273 clinical trial?
NCT06149273 is sponsored by University of Turku. The principal investigator is Päivi Korhonen, PhD at University of Turku. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.